DIM
TCRT icon

Delta Investment Management’s Alaunos Therapeutics TCRT Stock Holding History

Delta Investment Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-96
Closed -$47K – 160
2020
Q2 		$47K Sell
96
-77
-45% -$34.3K 0.02% 148
2020
Q1 		$63K Sell
173
-44
-20% -$22.8K 0.05% 101
2019
Q4 		$153K Buy
217
+44
+25% +$30.3K 0.06% 133
2019
Q3 		$110K Buy
+173
New +$137K 0.06% 135

Other funds holding TCRT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Delta Investment Management's TCRT Position: Q3 2020 in Review

Delta Investment Management sold out of Alaunos Therapeutics (TCRT) in Q3 2020, closing a stake of 96 shares — an estimated $47K sold.

Delta Investment Management first reported a position in TCRT in Q3 2019 and held it in 4 quarters. The position peaked at $153K in Q4 2019. 154 funds tracked by Wall St. Rank hold TCRT as of Q3 2020.

  • Delta Investment Management reported no remaining Alaunos Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Delta Investment Management sold 96 Alaunos Therapeutics shares in Q3 2020, an estimated $47K.
  • Delta Investment Management first reported a position in Alaunos Therapeutics in Q3 2019 and held it in 4 quarters.
  • Delta Investment Management's Alaunos Therapeutics position peaked at $153K in Q4 2019.
  • 154 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2020.

Based on Delta Investment Management's 13F filing for Q3 2020, filed 12 Nov 2020.